Discrepancies are more pronounced at elevated blood pressure levels
MONDAY, Aug. 18, 2025 (HealthDay News) — Differences across blood pressure (BP) measurement methods show clinically important variance in readings, according to a review published online Aug. 19 in the Annals of Internal Medicine.
Jiunn-Tyng Yeh, M.D., Ph.D., from Taipei Veterans General Hospital in Taiwan, and colleagues conducted a systematic literature review to identify studies comparing BP measurement methods of office-based BP measurement. A network meta-analysis was conducted to assess agreement between methods and clinical implications.
Based on 65 studies (40,022 participants), the researchers found that compared with research office systolic BP measurement, the pooled mean differences from corresponding systolic BPs were 2.69 mm Hg higher for convenient office BP measurement, 4.57 mm Hg lower for automated office BP measurement, 4.59 mm Hg lower for home BP measurement, 4.22 mm Hg lower for daytime ambulatory BP measurement, 18.14 mm Hg lower for nighttime ambulatory BP measurement, and 8.63 mm Hg lower for 24-hour ambulatory BP measurement. Higher reference BP levels were associated with larger differences between research office and other BP measurement methods.
“We showed that the differences among BPM methods are not fixed, but instead depend on the underlying systolic BP and diastolic BP,” the authors write. “Thus, guidelines should reconsider current benchmarks across BP measurement methods.”
Abstract/Full Text (subscription or payment may be required)
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians
Antenatal Complications Increased With Maternal Multiple Long-Term Conditions
Phthalates From Personal Care Products Tied to Higher BP in Pregnancy
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia
Exercise Link to Dementia Varies by Physical Activity Domain
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy